SCIENTURE HOLDINGS, INC. Investing Cash Flow
SCIENTURE HOLDINGS, INC. (SCNX) reported Investing Cash Flow of $27.55 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2024-09-30 was $120.98K.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2024-06-30 was -$774.00.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2024-03-31 was $27.43M, a 8133.14% increase year-over-year.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2024 was $27.55M.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$275.72K.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$427.85K.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2021 was -$22.60K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $120.98K derived: sum of 2 quarters · filed 2026-03-30 | $120.20K derived: sum of 3 quarters · filed 2026-03-30 | $27.55M 10-K · filed 2026-03-30 |
| 2024-09-30 | $120.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $120.20K derived: sum of 2 quarters · filed 2025-11-12 | $27.55M 10-Q · filed 2025-11-12 | $27.20M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$774.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $27.43M 10-Q · filed 2025-08-12 | $27.08M derived: sum of 3 quarters · filed 2025-08-12 | $26.87M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $27.43M 10-Q · filed 2025-05-12 | $27.08M derived: sum of 2 quarters · filed 2025-05-12 | $26.88M derived: sum of 3 quarters · filed 2025-05-12 | $26.82M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$557.11K derived: sum of 2 quarters · filed 2025-03-26 | -$608.91K derived: sum of 3 quarters · filed 2025-03-26 | -$275.72K 10-K · filed 2025-03-26 |
| 2023-09-30 | -$207.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$258.91K derived: sum of 2 quarters · filed 2024-11-06 | $74.28K 10-Q · filed 2024-11-06 | -$40.66K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$51.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $281.39K 10-Q · filed 2024-08-09 | $166.45K derived: sum of 3 quarters · filed 2024-08-09 | $110.72K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $333.20K 10-Q · filed 2024-06-26 | $218.25K derived: sum of 2 quarters · filed 2024-06-26 | $162.52K derived: sum of 3 quarters · filed 2024-06-26 | -$117.65K derived: sum of 4 quarters · filed 2024-06-26 |
| 2022-12-31 | -$114.94K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$170.67K derived: sum of 2 quarters · filed 2024-01-16 | -$450.85K derived: sum of 3 quarters · filed 2024-01-16 | -$427.85K 10-K · filed 2023-03-27 |
| 2022-09-30 | -$55.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-16 | -$335.90K derived: sum of 2 quarters · filed 2024-01-16 | -$312.90K 10-Q · filed 2024-01-16 | |
| 2022-06-30 | -$280.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18 | -$257.17K 10-Q · filed 2023-08-18 | ||
| 2022-03-31 | $23.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$22.60K 10-K · filed 2023-03-27 | |||
| 2020-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$14.00K derived: sum of 2 quarters · filed 2022-03-28 | -$14.00K derived: sum of 3 quarters · filed 2022-03-28 | -$37.51K 10-K · filed 2022-03-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-25 | $0.00 derived: sum of 2 quarters · filed 2021-10-25 | -$23.50K 10-Q · filed 2021-10-25 | -$105.76K derived: sum of 4 quarters · filed 2021-10-25 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26 | -$23.50K 10-Q · filed 2021-07-26 | -$105.76K derived: sum of 3 quarters · filed 2021-07-26 | -$105.76K derived: sum of 4 quarters · filed 2021-07-26 |
| 2020-03-31 | -$23.50K 10-Q · filed 2021-04-26 | -$105.76K derived: sum of 2 quarters · filed 2021-04-26 | -$105.76K derived: sum of 3 quarters · filed 2021-04-26 | -$145.76K derived: sum of 4 quarters · filed 2021-04-26 |
| 2019-12-31 | -$82.25K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$82.25K derived: sum of 2 quarters · filed 2021-03-29 | -$122.25K derived: sum of 3 quarters · filed 2021-03-29 | -$332.25K 10-K · filed 2021-03-29 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | -$40.00K derived: sum of 2 quarters · filed 2020-10-26 | -$250.00K 10-Q · filed 2020-10-26 | |
| 2019-06-30 | -$40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | -$250.00K 10-Q · filed 2020-07-27 | ||
| 2019-03-31 | -$210.00K 10-Q · filed 2020-05-04 | |||
| 2018-12-31 | -$265.28K 10-K · filed 2020-03-30 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 10-K · filed 2018-03-02 | ||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$78.00K 10-K · filed 2018-03-02 | ||
| 2016-09-30 | -$78.00K 10-Q · filed 2017-11-07 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 10-Q · filed 2014-10-30 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-21 | |||
| 2013-12-31 | $21.97K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $18.70K derived: sum of 2 quarters · filed 2015-03-23 | $10.99K 10-K · filed 2015-03-23 | |
| 2013-09-30 | -$3.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$10.98K 10-Q · filed 2014-10-30 | ||
| 2013-06-30 | -$7.71K 10-Q · filed 2014-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |